Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration

AIDS

Volumn 17, Issue 13, 2003, Pages 1897-1906

  Eggers, Christian ^a   Hertogs, Kurt ^b   Stürenburg, Hans Jörg ^a   Van Lunzen, Jan ^a   Stellbrink, Hans Jürgen ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Virco BVBA   (Belgium)

Author keywords

Antiretroviral therapy; Drug interactions; HIV drug resistance; HIV encephalopathy; Pharmacokinetics; Resistance mutations

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RITONAVIR; VIRUS RNA;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INFECTION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COGNITIVE DEFECT; DISEASE SEVERITY; FEMALE; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IC 50; INFECTION CONTROL; KINETICS; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SCORING SYSTEM; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD; VIRUS REPLICATION; VIRUS RESISTANCE;

ADULT; AGED; AIDS DEMENTIA COMPLEX; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DRUG RESISTANCE, VIRAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RNA, VIRAL; VIRAL LOAD; VIRUS REPLICATION;

EID: 0042830227     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200309050-00008     Document Type: Article

References (53)

1. Price RW, Brew BJ. The AIDS dementia complex. J Infect Dis 1988, 158:1079-1083.
2. Mc Arthur JC, Mc Clernon DR, Cronin MF, Nance-Sproson TE, Saah JA, St Clair M, et al. Relationship between HIV-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol 1997, 42:689-698.
3. Ellis R, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, et al. Cerebrospinal fluid human immunodeficiency virus 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immundodeficiency syndrome. Ann Neurol 1997, 42:679-688.
4. Wiley CA, Achim CL, Christopherson C, Kidane Y, Kwok S, Masliah E, et al. HIV mediates a productive infection of the brain. AIDS 1999, 13:2055-2059.
5. Cinque P, Vago L, Ceresa D, Mainini F, Terreni MR, Vagani A, et al. Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis. AIDS 1998, 12:389-394.
6. Jones MV, Bell JE, Nath A. Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia. AIDS 2000, 14:2709-2713.
7. Teo I, Veryard C, Barnes H, An SF, Jones M, Lantos PL, et al. Circular forms of unintegrated HIV-1 DNA and high levels of viral protein expression: association with dementia and multi-nucleated giant cells in the brains of patients with AIDS. J Virol 1997, 71:2928-2933.
8. Pang S, Koyanagi Y, Miles S, Wiley C, Vinters HV, Chen IS. High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients. Nature 1990, 343:85-89.
9. Steuler H, Storch-Hagenlocher B, Wildemann B. Distinct populations of HIV type 1 in blood and CSF. AIDS Res Hum Retroviruses 1992, 8:53-59.
10. Epstein LG, Kuiken C, Blumberg BM, Hartman S, Sharer LR, Clement M, et al. HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies. Virology 1991, 180:583-590.
11. Keys B, Karis J, Fadeel B, Valentin A, Norkrans G, Hagberg L, et al. V3 sequences of paired HIV-1 isolates from blood and cerebrospinal fluid cluster according to host and show variation related to the clinical stage of disease. Virology 1993, 196:475-483.
12. Korber BT, Kunstman KJ, Patterson BK, Furtado M, McEvilly MM, Levy R, et al. Genetic differences between blood- and brain-derived viral sequences from HIV-1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 1994, 68:7467-7481.
13. Wong JK, Ignacio CC, Torriani F, Havlir D, Fitch NJS, Richman DD. In vivo compartmentalization of HIV: evidence from the examination of pol sequences from autopy tissues. J Virol 1997, 71:2059-2071.
14. Zhang K, Hawken M, Rana F, Welte FJ, Gartner S, Goldsmith MA, et al. Human immunodeficiency virus type 1 clade a and d neurotropism: molecular evolution, recombination, and coreceptor use. Virology 2001, 283:19-30.
15. Brew BJ, Evans L, Byrne C, Pemberton L, Hurren L. The relationship berween AIDS dementia complex and the presence of macrophage tropic and non-syncytium inducing isolates of HIV-1 in the cerebrospinal fluid. J Neurovirol 1996, 2:152-157.
16. Eggers C, van Lunzen J, Buhk T, Stellbrink HJ. HIV infection of the central nervous system is characterized by rapid turnover of viral RNA in the cerebrospinal fluid. J Acquir Immune Defic Syndr 1999, 20:259-264.
17. Morris L, Silber E, Sonnenberg P, Eintracht S, Nyoka S, Lyons SF, et al. High HIV-1 RNA load in the cerebrospinal fluid from patients with lymphocytic meningitis. J Infect Dis 1998, 177:473-476.
18. Schrager LK, d'Souza MP. Cellular and anatomical reseroirs of HIV-1 in patients receiving potent antiretroviral combination therapy. JAMA 1998, 280:67-71.
19. Chun TW, Davey RT, Jr., Ostrowski M, Shawn Justement J, Engel D, Mullins JI, et al. Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy. Nature Med 2000, 6:757-761.
20. Cunningham PH, Smith DG, Satchell C, Cooper DA, Brew B. Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid. AIDS 2000, 14:1949-1954.
21. Stingele K, Haas J, Zimmermann T, Stingele R, Hubsch-Muller C, Freitag M, et al. Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy. Neurology 2001, 56:355-361.
22. Eggers C, Stuerenburg HJ, Schafft T, Zöllner B, Stellbrink HJ, van Lunzen J. Rapid clearance of human immunodeficiency virus from ventricular cerebrospinal fluid during antiretroviral treatment. Ann Neurol 2000, 47:816-819.
23. Foudraine NA, Hoetelmans RMW, Lange JMA, de Wolf J, van Benthem BHB, Maas IJ, et al. CSF HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine. Lancet 1998, 351:1547-1551.
24. Gisslén M, Hagberg L, Svennerholm B, Norkrans G. HIV-1 RNA is not detectable in the CSF during antiretroviral combination therapy [letter]. AIDS 1997, 11:1194.
25. Pialoux G, Fournier S, Moulignier A, Poveda JD, Clavel F, Dupont B. Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir (letter). AIDS 1997, 11:1302-1303.
26. Janssen RS, Working Group of the American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 1991, 41:778-785.
27. Reiber H, Felgenhauer K. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the CNS. Clin Chim Acta 1987, 163:319-328.
28. van Heeswijk RP, Hoetelmans RM, Harms R, Meenhorst PL, Mulder JW, Lange JM, et al. Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci Appl 1998, 719:159-168.
29. van Heeswijk RP, Hoetelmans RM, Meenhorst PL, Mulder JW, Beijnen JH. Rapid determination of nevirapine in human plasma by ion-pair reversed- phase high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci Appl 1998, 713:395-399.
30. Hoetelmans RM, Profijt M, Mennhorst PL, Mulder JW, Beijnen JH. Quantitative determination of (-)-2′-deoxy-3′-thiacytidine (lamivudine) in human plasma, saliva and cerebrospinal fluid by high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci Appl 1998, 713:387-394.
31. Hertogs K, de Bethune MP, Miller V, Ivens T, Schel P, Van Cauwenberge A, et al. A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs. Antimicrob Agents Chemother 1998, 42:269-276.
32. Perelson AS, Essunger P, Cao Y, Vesanen M, Hurley A, Saksela K, et al. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 1997, 387:188-191.
33. Enting RH, Hoetelmans RM, Lange JM, Burger DM, Beijnen JH, Portegies P. Antiretroviral drugs and the central nervous system. AIDS 1998, 12:1941-1955.
34. Staprans S, Marlowe N, Glidden D, Novakovic-Agopian T, Grant RM, Heyes M, et al. Time course of CSF response to antiretroviral therapy: evidence for variable compartmentalization of infection. AIDS 1999, 13:1051-1061.
35. Martin C, Albert J, Hansson P, Pehrsson P, Link H, Sonnerborg A. Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels. J Acquir Immune Defic Syndr 1998, 17:214-219.
36. Ellis RJ, Gamst AC, Capparelli E, Spector SA, Hsia K, Wolfson T, et al. Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology 2000, 54:927-936.
37. Cinque P, Presi S, Bestetti A, Pierotti C, Racca S, Boeri E, et al. Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid. AIDS Res Hum Retroviruses 2001, 17:377-383.
38. Gisolf EH, Enting RH, Jurriaans S, de Wolf F, van der Ende ME, Hoetelmans RM, et al. Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine. AIDS 2000, 14:1583-1589.
39. Weidenheim KM, Epshteyn I, Lyman WD. Immunocytochemical identification of T-cells in HIV-1 encephalitis: implications for pathogenesis of CNS disease. Mod Pathol 1993, 6:167-174.
40. von Herrath M, Oldstone MB, Fox HS. SIV-specific CTL in cerebrospinal fluid and brains of SIV-infected rhesus macaques. J Immunol 1995, 154:5582-5589.
41. Shaw GM, Harper ME, Hahn BH, Epstein LG, Gajdusek DC, Price RW, et al. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science 1985, 227:177-182.
42. Gabuzda DH, Ho DD, da la Monte SM, Hirsch MS, Rota TR, Sobel RA. Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann Neurol 1986, 20:289-295.
43. Koenig S, Gendelman HE, Orenstein JM, dal Canto MC, Pezeshkpour GH, Yungbluth M, et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986, 233:1089-1093.
44. Peudenier S, Hery C, Montagnier L, Tardieu M. Human microglia cells: characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1 infection. Ann Neurol 1991, 29:152-161.
45. Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD. Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol 1996, 39:705-711.
46. Bechmann I, Kwidzinski E, Kovac AD, Simburger E, Horvath T, Gimsa U, et al. Turnover of rat brain perivascular cells. Exp Neurol 2001, 168:242-249.
47. Williams KC, Hickey WF. Traffic of hematogenous cells through the central nervous system. Curr Top Microbiol Immunol 1995, 202:221-245.
48. Hickey WF, Williams KC. Mononuclear phagocyte heterogeneity and the blood-brain-barrier: a model for HIV-1 neuropathogenesis. In: The Neurology of AIDS. Edited by Gendelman HE, Lipton SA, Epstein L, Swindells S. New York: Chapman & Hall; 1998:61-72.
49. Ioannidis JP, Reichlin S, Skolnik PR. Long-term productive human immunodeficiency virus-1 infection in human infant microglia. Am J Pathol 1995, 147:1200-1206.
50. Igarashi T, Brown CR, Endo Y, Buckler-White A, Plishka R, Bischofberger N, et al. Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans. Proc Nat Acad Sci USA 2001, 98:658-663.
51. Budka H. Neuropathology of human immunodeficiency virus infection. Brain Pathol 1991, 1:163-175.
52. Glass JD, Fedor H, Wesselingh SL, McArthur JC. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 1995, 38:755-762.
53. Aleman S, Soderbarg K, Visco-Comandini U, Sitbon G, Sonnerborg A. Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy. AIDS 2002, 16:1039-1944.